# A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine

> **NCT06578585** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 43 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Ubrogepant
- **DRUG:** Lu AG09222
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06578585
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-13
- **Primary completion:** 2025-07-11
- **Final completion:** 2025-07-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06578585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06578585, "A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06578585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*